ArticleProceedings of the National Academy of Sciences of the United States of America2023

Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity.

Yuankun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.